Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo

Dendritic cells (DCs) loaded in vitro with Ag are used as cellular vaccines to induce Ag-specific immunity. These cells are thought to be responsible for direct stimulation of Ag-specific T cells, which may subsequently mediate immunity. In this study, in transgenic mouse models with targeted MHC class II expression specifically on DO, we show that the DC vaccine is responsible only for partial CD4+ T cell activation, but to obtain optimal expansion of T cells in vivo, participation of endogenous,(resident) DO, but not endogenous B cells, is crucial. Transfer of Ag to endogenous DO seems not to be mediated by simple peptide diffusion, but rather by DC-DC interaction in lymph nodes as demonstrated by histological analysis. In contrast, injection of apoptotic or necrotic DC vaccines does not induce T cell responses, but rather represents an immunological null event, which argues that viability of DC vaccines can be crucial for initial triggering of T cells. We propose that viable DO from the DC vaccine must migrate to the draining lymph nodes and initiate a T cell response, which thereafter requires endogenous DO that present transferred Ag in order induce optimal T cell expansion. These results are of specific importance with regard to the applicability of DC vaccinations in tumor patients, where the function of endogenous DO is suppressed by either tumors or chemotherapy.